e.l.f. Beauty Is Down 53% From Its All-Time High. Is the Sell-Off an Overreaction?

e.l.f. Beauty’s growth is decelerating: net sales growth fell from 77% in FY2024 to 28% (FY2025e) and 25% (FY2026e), while analysts only expect revenue to rise 20% in FY2027 and 8% in FY2028. Despite stable gross margins around 71% and reduced China manufacturing dependence from ~100% (2019) to ~75%, tariffs and higher operating expenses are pressuring results. Valuation appears “cheap” (EV of $6.8B, trading at 17x this year’s adj. EBITDA), but the article expects stock stagnation unless organic growth re-accelerates.

Analysis

The core issue is not the headline valuation; it is that ELF’s multiple was built on a shelf-space and category-share expansion phase that is now normalizing. Once a brand has already saturated the easy distribution gains at TGT/WMT/ULTA, the next leg of growth typically depends on SKU innovation and sustained repeat rates — a much harder story to underwrite at a premium multiple. That makes the stock more vulnerable to any incremental miss in organic growth than the current P/E screen suggests.

The second-order risk is margin durability. If tariff pressure and China diversification keep nudging input costs higher, management faces a bad choice: protect share with discounting or protect margin with price increases that can slow velocity. Either path reduces operating leverage and makes the market less willing to pay for growth, while also encouraging retailers to optimize shelf space toward faster-turn or higher-margin beauty brands.

The key contrarian point is that the market may be treating this as a cheap consumer growth name, when it may be closer to a mature branded-CPG model with lower terminal growth and higher supply-chain risk. Over the next 1-3 months, the stock likely trades on guidance quality and evidence of organic vs acquisition-driven growth; over 6-18 months, rerating depends on whether international expansion or new hero products can reaccelerate true sell-through. What would falsify the bearish view is a clear re-acceleration in organic revenue and stable gross margin despite further supply-chain diversification costs.

Key Decisions for Investors

• Avoid initiating new long ELF at current levels; use rallies into earnings/guidance as a trim point unless management can show organic growth re-acceleration. Falsifier: organic revenue growth re-accelerates to high-teens or better for two consecutive quarters.
• Relative-value: long ULTA / short ELF for 1-3 months. ULTA has better pricing power and mix optionality if beauty demand stays healthy, while ELF’s multiple is more exposed to growth normalization.
• If entering tactically, use an ELF put spread into the next earnings event rather than outright short stock. The setup is a modest downside grind, not a crash; defined-risk options fit the thesis better than an aggressive directional short.
• Watch TGT and WMT as indirect beneficiaries if ELF growth slows: retailers can reallocate shelf space to private label or higher-margin beauty SKUs. If beauty category traffic weakens, however, that would be a falsifier for the retailer-positive read.